Winter Park, Florida--(Newsfile Corp. - February 18, 2025) - Adia (OTC Pink: ADIA) Med is proud to announce a strategic…
SHANGHAI, Feb. 17, 2025 /PRNewswire/ -- Nowadays, artificial intelligence (AI) technology is profoundly reshaping the landscape of the pharmaceutical and healthcare…
Company Raises $3.85M in Seed Funding led by Caduceus Capital Partners, with Participation from Bread and Butter Ventures; Announces Collaboration…
EDEN PRAIRIE, Minn., Feb. 13, 2025 /PRNewswire/ -- Starkey continues to be at the forefront of technology and innovation and…
DELRAY BEACH, Fla., Feb. 13, 2025 /PRNewswire/ -- The global remote patient monitoring market, valued at US$24.39 billion in 2023,…
Ad hoc announcement pursuant to Art. 53 LR AGAMREE® is the first product to receive an agreed federal price in…
First U.S. patients being treated with Lenmeldy™ (atidarsagene autotemcel) in a commercial setting; other launch efforts progressing well following Food…
GOMEKLI™ (mirdametinib) capsules and tablets for oral suspension GOMEKLI™ (mirdametinib) capsules and tablets for oral suspension Saqib Islam, SpringWorks Therapeutics…
GOMEKLI™ (mirdametinib) capsules and tablets for oral suspension GOMEKLI™ (mirdametinib) capsules and tablets for oral suspension Saqib Islam, SpringWorks Therapeutics…
Collaboration Aims to Develop First Intranasal Therapy for Mild Traumatic Brain Injury Aka Concussion, Establishing a Comprehensive Test-to-Treat PlatformSARASOTA, Fla.…
